Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioventus Inc BVS

Healthcare Medical Instruments & Supplies
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products... see more

Recent & Breaking News (NDAQ:BVS)

Bioventus Deadline Alert

Newsfile February 24, 2023

BVS Investors Have Opportunity to Lead Bioventus Inc. Securities Fraud Lawsuit

PR Newswire February 24, 2023

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Bioventus Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BVS

PR Newswire February 23, 2023

BIOVENTUS INC. (BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bioventus Inc. (BVS)

Newsfile February 23, 2023

Bioventus Shareholder Action Reminder

Newsfile February 22, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit and Upcoming Deadline - BVS

PR Newswire February 22, 2023

BIOVENTUS INC. (NASDAQ: BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bioventus Inc. (NASDAQ: BVS)

PR Newswire February 22, 2023

Bioventus Shareholder Action Reminder

Newsfile February 21, 2023

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Bioventus Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BVS

Newsfile February 21, 2023

BVS Investors Have Opportunity to Lead Bioventus Inc. Securities Fraud Lawsuit

PR Newswire February 21, 2023

Bioventus Shareholder Notice

Newsfile February 19, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit and Upcoming Deadline - BVS

Newsfile February 18, 2023

BIOVENTUS DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Bioventus To Contact Him Directly To Discuss Their Options

PR Newswire February 18, 2023

Bioventus Shareholder Action Reminder

Newsfile February 16, 2023

ROSEN, A LEADING AND RANKED FIRM, Encourages Bioventus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BVS

PR Newswire February 16, 2023

BIOVENTUS INC. (BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bioventus Inc. (BVS)

Newsfile February 16, 2023

Bioventus Deadline Alert

Newsfile February 15, 2023

BIOVENTUS INC. (NASDAQ: BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bioventus Inc. (NASDAQ: BVS)

PR Newswire February 15, 2023

BVS Investors Have Opportunity to Lead Bioventus Inc. Securities Fraud Lawsuit

PR Newswire February 15, 2023

Bioventus Shareholder Notice

Newsfile February 14, 2023